FDA Announces Final Guidance on Formal Meetings with Sponsors of Prescription Drug Products

Summary

The Food and Drug Administration (FDA) has released a final guidance document outlining the procedures for formal meetings between the FDA and sponsors or applicants of prescription drug products regulated by the Center for Drug Evaluation and Research (CDER) and the Center for Biologics Evaluation and Research (CBER).